- Fujifilm’s Avigan shows efficacy in treating COVID-19, company to seek approval.
- Fujifilm Holdings plans to seek regulatory approval as early as October.
- Favipiravir drug may also become the third treatment drug for COVID-19.
- Remdesivir developed by U.S. firm Gilead Sciences Inc. was given the green light in May to be used in Japan.
Tags : JAPAN COVID-19 DRUG, FUJIFILM HOLDINGS CORP., FUJIFILM AVIGAN DRUG, CORONAVIRUS, FAVIPIRAVIR DRUG, FUJIFILM TOYAMA CHEMICAL CO.,